Relationships of Cognitive Difficulties to Immune Measures, Depression and Illness Burden in Chronic Fatigue Syndrome

Journal Of Chronic Fatigue Syndrome

Volumn 1, Issue 2, 1995, Pages 23-41

  Lutgendorf, Susan ^a   Klimas, Nancy G ^a   Antoni, Michael ^a   Brickman, Andrew ^a   Fletcher, Mary Ann ^b  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0003004203     PISSN: 10573321     EISSN: 15470660     Source Type: Journal    
DOI: 10.1300/J092v01n02_03     Document Type: Article

References (49)

1. Millon C, Salvato F, Blaney N, Morgan R, Mantero-Atienza E, Klimas NG, Fletcher MA: A psychological assessment of chronic fatigue syndrome/ chronic Epstein-Ban Virus patients Psycho/ Health. 1989; 3: 131–141.
2. Sandman CA, Baron JL, Nackoul K, Goldstein J, Fidler F. Memory defi-cits associated with chronic fatigue immune dysfunction syndrome Biol Psychia-try. 1993;33:618–623.
3. Allay HT, Toner BB, Brooker H, Abbey SE, Salit I, Garfinkel PE. The neu-ropsychological dimensions of postinfectious neuromyasthenia (Chronic fatigue syndrome): a preliminary report Ini J Psych Med. 1990; 20(2): 141–149.
4. Grafman JA, Johnson R, Scheffers M: Cognitive and mood-slate changes inpatients with chronic fatigue syndrome. Rev Inf Dis. 1991; 13, Suppl. 1; 45–52.
5. Brickman A, Imia AF. Psychological and cognitive aspects of chronic fa-tigue syndrome. In: Goodnick P. Klimas N. Chronic fatigue and related immune deficiency syndromes. American Psychiatric Press: Washington, D.C., in press.
6. Caliguri M, Murray C. Buchwald D, Levine H, Cheney P. Peterson D, Ko-maroff AL Ritsz J: Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome. J Immunol. 1987; 139: 3306–3313.
7. Klimas NG, Morgan R, Salvato F, Fletcher MA. Immunologic Abnormali-ties of Chronic Fatigue Syndrome/ Clin Microbiol. 1990; 28: 1403–1410.
8. Landy AL, Jessop C, Lennette ET, Levy JA. Chronic fatigue syndrome: clin-ical condition associated with immune activation Lancet. 1991; 338: 1403–1410.
9. Lloyd AR, Wakefield D, Boughton CR, Dwyer JM. Immunological abnor-malities in the chronic fatigue syndrome Med J Australia 1989; 151: 122–124.
10. Patarca R, Fletcher MA, Klimas NG: Immunological correlates of chronic fatigue syndrome. In P. Goodnick & N. Klimas (eds.) Chronic fatigue and related immune deficiency syndromes, American Psychiatric Press: Washington, D.C., in press.
11. Cheney PR: CFIDS Diagnosis for the practicing physician. In K. Dayger (Ed.) Review of Mainstream CFIDS Research in the USA. JCC CFIDS Program, Rochester NY, 1992; pp. 8–36.
12. Sandman CA, Barron JL, Nackoul KA, Fidler PL, Goldstein J: Is there a chronic fatigue syndrome (CFS) dementia? In B. Hyde, P. Levine, and J. Gold-stein, The Clinical and Scientific Basis of Myalgic Encephalomyelitisl Chronic Fa-tigue Syndrome. Nightingale Research Foundation. Ottowa Canada. 1992; 467–479.
13. Herbert TB, Cohen S. Depression and immunity: a meta-analytic review Psycho' Bull. 1993; 113:472–486.
14. Holmes CP, Kaplan JE. Gailiz NM, et al.: Chronic fatigue syndrome: a working case definition. Ann Ini Med. 1988; 108: 387–389.
15. Karnofsky DA, Abelmann WH, Craver LF, Burchenal JH. The Use of the nitrogen mustards in the palliative treatment of carcinoma Cancer. 1948; 1: 634–652.
16. Fletcher MA, Baron G, Ashman M, Fischi M, Klimas N. Use of whole blood methods in assessment of immune parameters in immunodeficiency slates Diag Clin Immunol. 1987; 5:69–81.
17. Fletcher MA, Azen S. Adelsberg B, et al.: Immu nop heno typing in a multi-center study: the transfusion safety study experience. Clin Immunol Immunopath. 1989; 52: 38-7.
18. Fletcher MA, Klimas NG, Morgan R, Gjerset G: Lymphocyte Proliferation Assays. In Manual of Clinical Laboratory Immunology, 41h edition., Rose, N. and Fahey, J, eds. Amer. Soc. Microbiology. 1992; 213–219.
19. Baron GC, Klimas NG, Fischi MA, Fletcher MA. Decreased natural cell-mediated cytotoxicity per effector cell in acquired immunodeficiency syndrome Diag Immunol. 1985; 3: 197–204.
20. Patarca R, Klimas NG, Luglgendorf S, Antoni M, Fletcher MA. Dysregu-lated expression of tumor necrosis factor in the chronic fatigue immune dysfunc-tion syndrome Interrelationship with cellular sources and soluble immune media-tor expression patterns. Clin In/Dis. 1994; 18(Suppl 1), S147–S153.
21. Spizer RL, Williams JBW, Gibbon M, First MB: Structured Clinical Inter-view for DSMIII-R. American Psychiatric Press 1990, Washington, D.C.
22. McNair DM, Kahn RJ: The Cognitive Difficulties Scale, In Thomas Crook, Steven Ferris, & Raymond Bartus, (eds.) Assessment in Geriatric Psycho-pharmacology. Mark Powley Associates, New Canaan: CN. 1983; pp. 137–143
23. Grober E., Buschke H: Genuine memory deficits in dementia Developmen-tal N europsychol. 1987; 3: 13-36.
24. Mirsky AF. Behavioral and psychophysiological markers of disordered attention Environmental Health Perspectives. 1987; 74: 191–199.
25. Rosvold HE, Mirsky AF, Sarason I, Bransome ED, Beck LH.A continuous performance test of brain damage. Journal o/ Consulting Psychology. 1956; 20: 334–350.
26. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Pro-file: Development and final revision of a health status measure Medical Care. 1981; 19(8): 787–807.
27. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh I.An inventory for measuring depression Archives oj General Psychiatry. 1981; 5: 561–571.
28. Hamilton MA.A rating scale for depression. Journal of Neurology, Neuro-surgery, and Psychiatry. 1960; 23: 56–62.
29. Weingarter H. Autonomic and effort-demanding cognitive processes in de-pression. In: Poon LW, ed. Handbook o/Clinical Memory Memory Assessment in Adults. Washington D.C. American Psychiatric Association1984; 41, 484–486.
30. Irwin M, Patterson T, Smith TL, Caldwell C, Brown SA, Gillin JC, Grant I. Reduction of immune function in life stress and depression Biological Psychia-try- 1990; 27: 22–230.
31. Irwin M, Caldwell C, Smith TL, Brown S, Schuckil MA, Gillin C. Major depressive disorder, alcoholism, and reduced natural killer cell cytotoxicity Ar-chives of General Psychiatry. 1990; 47: 713–719.
32. Schleifer SJ, Keller SE, Bond RN, Cohen J, Stein M. Major depressive dis-order: role of age, sex, severity and hospitalization Archives of General Psychia-try. 1989;46:81–87.
33. Sandman CA: Memory Deficits in CFIDS. In K. Daygcr (Ed.) Review of Mainstream CFIDS Research in the USA, 1992, pp. 170–177. CFIDS Program: Rochester NY.
34. Kalon WJ, Buchwald D, Simon GE, Mease P, Roy-Byrne P, Rosso J: Psy-chiatric illness in chronic fatigue syndrome versus rheumatoid arthritis. Paper presented at the American Psychiatric Association Convention, May, 15, 1990.
35. Kreusi MJ, Dale J, Straus SE. Psychiatric diagnoses in patients who have chronic fatigue syndrome. Journal of Clinical Psychiatry. 1989; 50: 53–56.
36. Wessely S, Powell R. Fatigue syndromes: a comparison of chronic postvi-ral fatigue with neuromuscular and affective disorders. Journal of Neurology, Neurosurgery, and Psychiatry. 1989; 52: 940–948.
37. Abbey SE, Garfinkel PE. Chronic fatigue syndrome and depression: cause, effect, or covariate Reviews of Infectious Diseases. 1991; 13 (Suppl 1): S73–S83.
38. Huber C, Batchelor JR. Fuchs D, el al.: Immune response associated pro-duction of neopterin. Release from macrophages primarily under control of inier-feron-gamma. J Exp Med. 1984; 160: 310–316.
39. Gupta S, Vayuvegula BA.A comprehensive immunological study in chronic fatigue syndrome Scad J Immunol. 1991; 33: 319–327.
40. Magreiter R, Fuchs D. Hausen A, el al.: Neopterin as a new biochemical marker for diagnosis of allograft rejection. Transplantation. 1983; 36: 650–653.
41. Hannonen P. Tikanoja S, Hakola M, Mottonen T, Vijnijja L, Oka M: Uri-nary neopterin index as a measure of rheumatoid activity Scad J Rheumatol. 1986; 29: 1063–1070.
42. Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP, Wachter H. Neopterin as a marker for activated cell mediated immunity: application in HIV infection Immunology Today. 1988; 9(5): 150–154.
43. Fuchs D, Hausen A. Koffler M, et al.: Neopterin as an index of immune response in patients with tuberculosis. Lung. 1984; 162: 337–346.
44. Reibnegger G, Boonpucknavig V. Fuch D, et al.: Urinary neopterin excre-tion is elevated in patients with malaria. Trans R Soc Trop Med Hyg. 1984; 78: 545–546.
45. Fuchs D, Moller AA, Reibnegger G, et al.: Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/psychiatric symptoms. J AIDS. 1990; 3: 873–876.
46. Sonnerborg A, Saaf. J. Alexius B, et al.: Quantitative detection of brain ab-errations in human immundeficiency virus type 1-infected individuals by magnet-ic resonance imaging. J Inf Dis. 1990; 162: 1245–1251.
47. Buchwald D, Cheney PR, Peterson DL, Henry B, et al.: Chronic illness characterized by faligue, neurologic and immunologic disorders and active human herpesvirus 6 type infection. Ann Int Med. 1992; 116: 103–113.
48. Klimas NG, Morgan R. Salvato F, Van Reil F, Millón C, Fletcher MA: Chronic Fatigue Syndrome and Psychoneuroimmunoiogy. In Stress and Disease Progression: Perspectives in Behavioral Medicine. Schneiderman, N., McCabe, P. and Baum, A., eds. Lawrence Erlbaum, Assoc, Hillsdale, NJ, 1992.
49. Lloyd AR, Hickie I, Hickie C, Dwyer J, Wakefield D. Cell mediated im-munity in patients with chronic faligue syndrome, healthy control subjects, and patients with major depression. Clinical Experimental Immunology. 1992; 87: 76–79.